Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × Ipilimumab × 1 year × Clear all

Sponsor

Conditions

Melanoma 65 Carcinoma, Renal Cell 33 Carcinoma, Non-Small-Cell Lung 33 Neoplasm Metastasis 22 Colorectal Neoplasms 13 Carcinoma, Hepatocellular 13 Brain Neoplasms 13 Skin Neoplasms 11 Neoplasms 11 Uveal Melanoma 10 Squamous Cell Carcinoma of Head and Neck 10 Lung Neoplasms 10 Ovarian Neoplasms 9 Kidney Neoplasms 9 Urinary Bladder Neoplasms 8 Sarcoma 8 Prostatic Neoplasms 8 Carcinoma, Transitional Cell 7 Small Cell Lung Carcinoma 6 Pancreatic Neoplasms 6 Glioblastoma 6 Colonic Neoplasms 6 Carcinoma, Merkel Cell 6 Recurrence 5 Multiple Myeloma 5 Mesothelioma, Malignant 5 Mesothelioma 5 Carcinoma, Neuroendocrine 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4

Interventions

Cyclophosphamide 80 Rituximab 77 Prednisone 45 Doxorubicin 39 Lenalidomide 35 Vincristine 32 fludarabine 27 polatuzumab vedotin 25 Magnetic Resonance Spectroscopy 24 Gemcitabine 23 Etoposide 23 Specimen Handling 22 Oxaliplatin 19 Biopsy 18 CT-P10 17 glofitamab 15 zanubrutinib 14 ibrutinib 13 fludarabine phosphate 13 tafasitamab 12 obinutuzumab 12 axicabtagene ciloleucel 12 venetoclax 10 pembrolizumab 10 deltacortene 10 Bendamustine Hydrochloride 10 prednylidene 9 Prednisolone 9 Nivolumab 9 Immunotherapy, Adoptive 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡